Archives
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Efficient iPSC Differentiation to Retinal Ganglion Cells via
2026-05-29
This study introduces a chemically defined protocol using dual SMAD and Wnt pathway inhibition to achieve highly efficient and reproducible differentiation of induced pluripotent stem cells (iPSCs) into retinal ganglion cells (RGCs). The findings provide a foundation for scalable, standardized RGC generation, directly addressing key challenges in glaucoma and neurodegenerative disease modeling.
-
JHU-083 (SKU BA7770): Reliable Glutaminase Pathway Research
2026-05-29
This article provides scenario-driven guidance for deploying JHU-083 (SKU BA7770) in cell viability and cytotoxicity assays. Drawing from recent literature and validated protocols, it demonstrates how this 6-diazo-5-oxo-L-norleucine precursor ensures reproducible, selective glutaminase inhibition in neuroscience and redox biology research. Key advantages—purity, solubility, and data-backed workflow compatibility—are highlighted for experimental reliability.
-
Palomid 529: Applied PI3K/Akt/mTOR Inhibition in Cancer Rese
2026-05-28
Palomid 529 (P529) delivers robust, dual mTORC1/2 inhibition for dissecting metastasis and therapy resistance, particularly in PI3K/Akt-driven cancers. This guide translates the latest mechanistic findings and quantitative protocols into actionable workflows, with practical troubleshooting tips for reproducible results.
-
Isolation and Functional Study of HLA-G+ EVTs in Maternal-Fe
2026-05-28
This protocol paper introduces a robust methodology for isolating and culturing primary HLA-G+ extravillous trophoblasts (EVTs) from distinct placental sites, enabling advanced investigation of maternal-fetal immune interactions. The approach supports both primary EVT cultures and EVT-like cell lines, laying a foundation for mechanistic studies of immunomodulation at the maternal-fetal interface.
-
Reactive Oxygen Species Assay Kit: Precision in Live-Cell RO
2026-05-27
Leverage the APExBIO Reactive Oxygen Species Assay Kit for high-sensitivity, quantitative ROS measurement in live cells. This guide details robust workflows and advanced applications—plus troubleshooting tips rooted in recent breakthroughs at the intersection of cancer research and redox biology.
-
CPI-613: Applied Workflows in Tumor Cell Metabolism Studies
2026-05-27
CPI-613 (6,8-bis(benzylsulfanyl)octanoic acid) empowers researchers to dissect and modulate mitochondrial metabolism in cancer models with unprecedented specificity. Drawing on the latest evidence, this guide translates mechanistic insights into practical applications and troubleshooting strategies for apoptosis assays and tumor metabolism workflows.
-
Drosophila Keap1 Forms Nuclear Condensates Under Oxidative S
2026-05-26
This study reveals that the Drosophila Keap1 ortholog (dKeap1) assembles stable nuclear condensates in response to oxidative stress, mediated by its intrinsic domain structure. These findings redefine the nuclear functions of Keap1 in stress response and chromatin regulation, providing new mechanistic insight into biomolecular condensate biology.
-
Verteporfin Workflows: Advanced Photodynamic & Autophagy Ass
2026-05-26
Verteporfin enables dual-action research workflows for photodynamic therapy and light-independent autophagy inhibition, uniquely supporting both apoptosis and senescence studies. This article delivers stepwise protocols, troubleshooting strategies, and key insights for maximizing experimental impact using APExBIO's Verteporfin.
-
Gamma-Linolenic Acid (GLA): A Systems Biology Perspective
2026-05-25
Explore Gamma-linolenic acid (GLA) as an omega-6 fatty acid with anti-inflammatory and cytoprotective properties. This article offers a systems biology analysis integrating molecular mechanisms, workflow protocols, and new cross-talk between lipid metabolism and humoral immunity.
-
Oligomycin A in Immunometabolic Assays: Mechanistic and Prot
2026-05-25
Explore how Oligomycin A, a mitochondrial ATP synthase inhibitor, enables advanced immunometabolic research by dissecting macrophage metabolism and tumor adaptation. This article delivers protocol intelligence and reference-backed guidance for researchers seeking to leverage Oligomycin A in cutting-edge cancer metabolism studies.
-
PreScission Protease: Precision Tag Cleavage for Nuclear Pro
2026-05-24
PreScission Protease (PSP) unlocks precise, low-temperature cleavage of fusion protein tags, enabling the isolation of functional proteins for condensate and chromatin research. This guide translates advanced workflows and troubleshooting strategies for nuclear protein studies, leveraging APExBIO’s optimized HRV 3C protease technology.
-
Eltanexor (KPT-8602): Optimizing XPO1 Inhibition in Cancer R
2026-05-23
Eltanexor (KPT-8602) empowers cancer research with potent, selective XPO1 inhibition, enabling precise modulation of nuclear export pathways in both hematological and solid tumor models. This guide delivers actionable workflows, troubleshooting insights, and evidence-backed advantages for integrating Eltanexor into experimental designs targeting nuclear export in cancer.
-
GPR35-KLF5 Circuitry Decodes Damage for Colonic Repair in DS
2026-05-22
This study identifies a metabolic gatekeeping mechanism in which GPR35 senses tryptophan catabolites to trigger KLF5-dependent repair of damaged colonic epithelium. The findings clarify how intestinal epithelial cells decode mucosal injury signals and orchestrate regenerative responses, informing more precise interventions for ulcerative colitis.
-
p-Cresyl Sulfate Drives VIC Calcification via Klotho/SIRT1 P
2026-05-22
The reference study elucidates how p-Cresyl sulfate (p-tolyl hydrogen sulfate), a major uremic toxin, promotes calcification in aortic valvular interstitial cells by disrupting klotho and SIRT1 signaling. These mechanistic insights establish new directions for biomarker development and therapeutic targeting in chronic kidney disease-associated calcific aortic valve disease.
-
Isolation and Characterization of Forsythoside E from Forsyt
2026-05-21
This study reports the isolation and structural elucidation of three new caffeoyl phenylethanoid glycosides and six known compounds, including Forsythoside E, from the fruits of Forsythia suspensa. The findings provide a foundation for the mechanistic and translational research now emerging around Forsythoside E as a macrophage metabolic modulator.